Literature DB >> 15123671

AML1/Runx1 recruits calcineurin to regulate granulocyte macrophage colony-stimulating factor by Ets1 activation.

Hebin Liu1, Magnus Holm, Xiao-Qi Xie, Magnus Wolf-Watz, Thomas Grundström.   

Abstract

Acute myeloid leukemia 1 (AML1), also denoted Runx1, is a transcription factor essential for hematopoiesis, and the AML1 gene is the most common target of chromosomal translocations in human leukemias. AML1 binds to sequences present in the regulatory regions of a number of hematopoiesis-specific genes, including certain cytokines such as granulocyte macrophage colony-stimulating factor (GM-CSF) up-regulated after T cell receptor stimulation. Here we show that both subunits of the Ca(2+)/calmodulin-dependent protein phosphatase calcineurin (CN), which is activated upon T cell receptor stimulation, interact directly with the N-terminal runt homology domain-containing part of AML1. The regulatory CN subunit binds AML1 with a higher affinity and in addition also interacts with the isolated runt homology domain. The related Runx2 transcription factor, which is essential for bone formation, also interacts with CN. A constitutively active derivative of CN is shown to activate synergistically the GM-CSF promoter/enhancer together with AML1 or Runx2. We also provide evidence that relief of the negative effect of the AML1 sites is important for Ca(2+) activation of the GM-CSF promoter/enhancer and that AML1 overexpression increases this Ca(2+) activation. Both subunits of CN interact with AML1 in coimmunoprecipitation analyses, and confocal microscopy analysis of cells expressing fluorescence-tagged protein derivatives shows that CN can be recruited to the nucleus by AML1 in vivo. Mutant analysis of the GM-CSF promoter shows that the Ets1 binding site of the promoter is essential for the synergy between AML1 and CN in Jurkat T cells. Analysis of the effects of inhibitors of the protein kinase glycogen synthase kinase-3beta and in vitro phosphorylation/dephosphorylation analysis of Ets1 suggest that glycogen synthase kinase-3beta-phosphorylated Ets1 is a target of AML1-recruited CN phosphatase at the GM-CSF promoter.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15123671     DOI: 10.1074/jbc.M403173200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  Rapid evolutionary rewiring of a structurally constrained eye enhancer.

Authors:  Christina I Swanson; David B Schwimmer; Scott Barolo
Journal:  Curr Biol       Date:  2011-07-07       Impact factor: 10.834

2.  PP2B-mediated dephosphorylation of c-Jun C terminus regulates phorbol ester-induced c-Jun/Sp1 interaction in A431 cells.

Authors:  Ben-Kuen Chen; Chi-Chen Huang; Wei-Chiao Chang; Yun-Ju Chen; Ushio Kikkawa; Ken-ichi Nakahama; Ikuo Morita; Wen-Chang Chang
Journal:  Mol Biol Cell       Date:  2007-01-10       Impact factor: 4.138

3.  Overexpression of Ste20-related proline/alanine-rich kinase exacerbates experimental colitis in mice.

Authors:  Yutao Yan; Hamed Laroui; Sarah A Ingersoll; Saravanan Ayyadurai; Moiz Charania; Stephen Yang; Guillaume Dalmasso; Tracy S Obertone; Hang Nguyen; Shanthi V Sitaraman; Didier Merlin
Journal:  J Immunol       Date:  2011-06-24       Impact factor: 5.422

4.  Human natural killer cell receptor 2B4 (CD244) down-regulates its own expression by reduced promoter activity at an Ets element.

Authors:  Stephen O Mathew; Swapnil V Vaidya; Jong R Kim; Porunelloor A Mathew
Journal:  Biochem Biophys Res Commun       Date:  2007-02-07       Impact factor: 3.575

5.  A transcriptional map of the impact of endurance exercise training on skeletal muscle phenotype.

Authors:  Pernille Keller; Niels B J Vollaard; Thomas Gustafsson; Iain J Gallagher; Carl Johan Sundberg; Tuomo Rankinen; Steven L Britton; Claude Bouchard; Lauren G Koch; James A Timmons
Journal:  J Appl Physiol (1985)       Date:  2010-10-07

6.  Thymomegaly, microsplenia, and defective homeostatic proliferation of peripheral lymphocytes in p51-Ets1 isoform-specific null mice.

Authors:  Tsukasa Higuchi; Frank O Bartel; Masahiro Masuya; Takao Deguchi; Kelly W Henderson; Runzhao Li; Robin C Muise-Helmericks; Michael J Kern; Dennis K Watson; Demetri D Spyropoulos
Journal:  Mol Cell Biol       Date:  2007-03-05       Impact factor: 4.272

7.  IFN-γ-mediated hematopoietic cell destruction in murine models of immune-mediated bone marrow failure.

Authors:  Jichun Chen; Xingmin Feng; Marie J Desierto; Keyvan Keyvanfar; Neal S Young
Journal:  Blood       Date:  2015-10-21       Impact factor: 22.113

8.  Runx2 transcriptome of prostate cancer cells: insights into invasiveness and bone metastasis.

Authors:  Sanjeev K Baniwal; Omar Khalid; Yankel Gabet; Ruchir R Shah; Daniel J Purcell; Deepak Mav; Alice E Kohn-Gabet; Yunfan Shi; Gerhard A Coetzee; Baruch Frenkel
Journal:  Mol Cancer       Date:  2010-09-23       Impact factor: 27.401

9.  Differentiation-dependent interactions between RUNX-1 and FLI-1 during megakaryocyte development.

Authors:  Hui Huang; Ming Yu; Thomas E Akie; Tyler B Moran; Andrew J Woo; Nathan Tu; Zachary Waldon; Yin Yin Lin; Hanno Steen; Alan B Cantor
Journal:  Mol Cell Biol       Date:  2009-05-26       Impact factor: 4.272

10.  Expression of GM-CSF Is Regulated by Fli-1 Transcription Factor, a Potential Drug Target.

Authors:  Xuan Wang; Mara Lennard Richard; Pengfei Li; Brittany Henry; Steven Schutt; Xue-Zhong Yu; Hongkuan Fan; Weiru Zhang; Gary Gilkeson; Xian K Zhang
Journal:  J Immunol       Date:  2020-12-02       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.